Casein kinase: The triple meaning of a misnomer

Biochemical Journal

Volumn 460, Issue 2, 2014, Pages 141-156

  Venerando, Andrea ^a,b   Ruzzene, Maria ^a,b   Pinna, Lorenzo A ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

Author keywords

Cancer; Casein kinase 1 (CK1); Casein kinase 2 (CK2); Family with sequence similarity 20C (Fam20C); Genuine casein kinase (G CK); Neurodegeneration

Indexed keywords

4,5,6,7 TETRABROMO 2 DIMETHYLAMINO 1H BENZIMIDAZOLE; 5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ANTINEOPLASTIC AGENT; CASEIN KINASE; CASEIN KINASE I; CASEIN KINASE II; CIBG 300; CIGB 300; CKI 7; CX 4945; CYCLOPEPTIDE; D 4476; DENTIN MATRIX PROTEIN 4; ELLIPTICINE DERIVATIVE; FAMILY WITH SEQUENCE SIMILARITY 20C PROTEIN; PF 4800567; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE INHIBITOR; QUINOLINE DERIVATIVE; SPHINGOSINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BIOMINERALIZATION; CALCIFICATION; CANCER MODEL; CONSENSUS SEQUENCE; DRUG TARGETING; ENZYME STRUCTURE; GOLGI COMPLEX; HUMAN; INFECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

CASEIN KINASE II; CASEIN KINASES; CASEINS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GOLGI APPARATUS; HUMANS; LACTATION; PHOSPHORYLATION;

EID: 84900504578     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140178     Document Type: Review

References (190)

1. Hammarsten, O. (1883) Zur Frage ob Casëin ein einheitlicher Stoff sei. Hoppe Seylers Z. Physiol. Chem. 7, 227-273
2. Lipmann, F. (1933) Über die Bindung der Phosphors̈aure in Phosphorproteinen. I. Biochem. Z. 262, 3
3. Burnett, G. and Kennedy, E. P. (1954) The enzymatic phosphorylation of proteins. J. Biol. Chem. 211, 969-980 PubMed
4. Lasa, M., Marin, O. and Pinna, L. A. (1997) Rat liver Golgi apparatus contains a protein kinase similar to the casein kinase of lactating mammary gland. Eur. J. Biochem. 243, 719-725 CrossRef PubMed
5. Xu, K., Ling, M.-T., Wang, X. and Wong, Y.-C. (2006) Evidence of a novel biomarker, αs1-Casein, a milk protein, in benign prostate hyperplasia. Prostate Cancer Prostatic Dis. 9, 293-297 CrossRef PubMed
6. Otaegui, D., Mostafavi, S., Bernard, C. C. A., Lopez de Munain, A., Mousavi, P., Oksenberg, J. R. and Baranzini, S. E. (2007) Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Immunol. 179, 4074-4082 PubMed
7. Vordenbäumen, S., Braukmann, A., Petermann, K., Scharf, A., Bleck, E., von Mikecz, A., Jose, J. and Schneider, M. (2011) Casein α s1 is expressed by human monocytes and upregulates the production of GM-CSF via p38 MAPK. J. Immunol. 186, 592-601 CrossRef PubMed
8. Meggio, F., Boulton, A. P., Marchiori, F., Borin, G., Lennon, D. P., Calderan, A. and Pinna, L. A. (1988) Substrate-specificity determinants for a membrane-bound casein kinase of lactating mammary gland. A study with synthetic peptides. Eur. J. Biochem. 177, 281-284 CrossRef PubMed
9. R. B. and Pinna, L. A. (1989) Synthetic fragments of beta-casein as model substrates for liver and mammary gland casein kinases. Eur. J. Biochem. 186, 459-464 CrossRef PubMed
10. Tagliabracci, V. S., Engel, J. L., Wen, J., Wiley, S. E., Worby, C. A., Kinch, L. N., Xiao, J., Grishin, N. V. and Dixon, J. E. (2012) Secreted kinase phosphorylates extracellular proteins that regulate biomineralization. Science 336, 1150-1153 CrossRef PubMed
11. Lolli, G., Cozza, G., Mazzorana, M., Tibaldi, E., Cesaro, L., Donella-Deana, A., Meggio, F., Venerando, A., Franchin, C., Sarno, S. et al. (2012) Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight. Biochemistry 51, 6097-6107 CrossRef PubMed
12. Ishikawa, M., Nakatani, H. and Hori, K. (2012) AtaA, a new member of the trimeric autotransporter adhesins from Acinetobacter sp. Tol 5 mediating high adhesiveness to various abiotic surfaces. PLoS ONE 7, e48830 CrossRef PubMed
13. Salvi, M., Cesaro, L., Tibaldi, E. and Pinna, L. A. (2010) Motif analysis of phosphosites discloses a potential prominent role of the Golgi casein kinase (GCK) in the generation of human plasma phospho-proteome. J. Proteome Res. 9, 3335-3338 CrossRef PubMed
14. Roach, P. J. (1991) Multisite and hierarchal protein phosphorylation. J. Biol. Chem. 266, 14139-14142 PubMed
15. Tagliabracci, V. S., Pinna, L. A. and Dixon, J. E. (2013) Secreted protein kinases. Trends Biochem. Sci. 38, 121-130 CrossRef PubMed
16. Bingham, E. W., Farrell, Jr, H. M. and Basch, J. J. (1972) Phosphorylation of casein. Role of the golgi apparatus. J. Biol. Chem. 247, 8193-8194 PubMed
17. Mercier, J. C. (1981) Phosphorylation of caseins, present evidence for an amino acid triplet code posttranslationally recognized by specific kinases. Biochimie 63, 1-17 CrossRef PubMed
18. Moore, A., Boulton, A. P., Heid, H. W., Jarasch, E.-D. and Craig, R. K. (1985) Purification and tissue-specific expression of casein kinase from the lactating guinea-pig mammary gland. Eur. J. Biochem. 152, 729-737 CrossRef PubMed
19. Duncan, J. S., Wilkinson, M. C. and Burgoyne, R. D. (2000) Purification of Golgi casein kinase from bovine milk. Biochem. J. 350, 463-468 CrossRef PubMed
20. Lasa-Benito, M., Marin, O., Meggio, F. and Pinna, L. A. (1996) Golgi apparatus mammary gland casein kinase: monitoring by a specific peptide substrate and definition of specificity determinants. FEBS Lett. 382, 149-152 CrossRef PubMed
21. Marin, O., Meggio, F. and Pinna, L. A. (1994) Design and synthesis of two new peptide substrates for the specific and sensitive monitoring of casein kinases-1 and-2. Biochem. Biophys. Res. Commun. 198, 898-905 CrossRef PubMed
22. Lasa, M., Chang, P. L., Prince, C. W. and Pinna, L. A. (1997) Phosphorylation of osteopontin by Golgi apparatus casein kinase. Biochem. Biophys. Res. Commun. 240, 602-605 CrossRef PubMed
23. Tibaldi, E., Arrigoni, G., Brunati, A. M., James, P. and Pinna, L. A. (2006) Analysis of a sub-proteome which co-purifies with and is phosphorylated by the Golgi casein kinase. Cell. Mol. Life Sci. 63, 378-389 CrossRef PubMed
24. Koike, T., Izumikawa, T., Tamura, J.-I. and Kitagawa, H. (2009) FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan-protein linkage region. Biochem. J. 421, 157-162 CrossRef PubMed
25. O'Sullivan, J., Bitu, C. C., Daly, S. B., Urquhart, J. E., Barron, M. J., Bhaskar, S. S., Martelli-Júnior, H., dos Santos Neto, P. E., Mansilla, M. A., Murray, J. C. et al. (2011) Whole-exome sequencing identifies FAM20A mutations as a cause of amelogenesis imperfecta and gingival hyperplasia syndrome. Am. J. Hum. Genet. 88, 616-620 CrossRef PubMed
26. Cho, S. H., Seymen, F., Lee, K.-E., Lee, S.-K., Kweon, Y.-S., Kim, K. J., Jung, S.-E., Song, S. J., Yildirim, M., Bayram, M. et al. (2012) Novel FAM20A mutations in hypoplastic amelogenesis imperfecta. Hum. Mutat. 33, 91-94 CrossRef PubMed
27. Barylko, B., Gerber, S. H., Binns, D. D., Grichine, N., Khvotchev, M., Südhof, T. C. and Albanesi, J. P. (2001) A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans. J. Biol. Chem. 276, 7705-7708 CrossRef PubMed
28. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912-1934 CrossRef PubMed
29. Xiao, J., Tagliabracci, V. S., Wen, J., Kim, S.-A. and Dixon, J. E. (2013) Crystal structure of the Golgi casein kinase. Proc. Natl. Acad. Sci. U.S.A. 110, 10574-10579 CrossRef PubMed
30. Niefind, K., Guerra, B., Pinna, L. A., Issinger, O. G. and Schomburg, D. (1998) Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 A° resolution. EMBO J. 17, 2451-2462 CrossRef PubMed
31. Brunati, A. M., Marin, O., Bisinella, A., Salviati, A. and Pinna, L. A. (2000) Novel consensus sequence for the Golgi apparatus casein kinase, revealed using proline-rich protein-1 (PRP1)-derived peptide substrates. Biochem. J. 351, 765-768 CrossRef PubMed
32. Raine, J., Winter, R. M., Davey, A. and Tucker, S. M. (1989) Unknown syndrome: microcephaly, hypoplastic nose, exophthalmos, gum hyperplasia, cleft palate, low set ears, and osteosclerosis. J. Med. Genet. 26, 786-788 CrossRef PubMed
33. Simpson, M. A., Hsu, R., Keir, L. S., Hao, J., Sivapalan, G., Ernst, L. M., Zackai, E. H., Al-Gazali, L. I., Hulskamp, G., Kingston, H. M. et al. (2007) Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development. Am. J. Hum. Genet. 81, 906-912 CrossRef PubMed
34. Fradin, M., Stoetzel, C., Muller, J., Koob, M., Christmann, D., Debry, C., Kohler, M., Isnard, M., Astruc, D., Desprez, P. et al. (2011) Osteosclerotic bone dysplasia in siblings with a Fam20C mutation. Clin. Genet. 80, 177-183 CrossRef PubMed
35. Simpson, M., Scheuerle, A., Hurst, J., Patton, M., Stewart, H. and Crosby, A. (2009) Mutations in FAM20C also identified in non-lethal osteosclerotic bone dysplasia. Clin. Genet. 75, 271-276 CrossRef PubMed
36. Rafaelsen, S. H., Raeder, H., Fagerheim, A. K., Knappskog, P., Carpenter, T. O., Johansson, S. and Bjerknes, R. (2013) Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification. J. Bone Miner. Res. 28, 1378-1385 CrossRef PubMed
37. Vogel, P., Hansen, G. M., Read, R. W., Vance, R. B., Thiel, M., Liu, J., Wronski, T. J., Smith, D. D., Jeter-Jones, S. and Brommage, R. (2012) Amelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null mice. Vet. Pathol. 49, 998-1017 CrossRef PubMed
38. Wang, X., Wang, S., Li, C., Gao, T., Liu, Y., Rangiani, A., Sun, Y., Hao, J., George, A., Lu, Y. et al. (2012) Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice. PLoS Genet. 8, e1002708 CrossRef PubMed
39. Wang, X., Wang, S., Lu, Y., Gibson, M. P., Liu, Y., Yuan, B., Feng, J. Q. and Qin, C. (2012) FAM20C plays an essential role in the formation of murine teeth. J. Biol. Chem. 287, 35934-35942 CrossRef PubMed
40. Jaureguiberry, G., De la Dure-Molla, M., Parry, D., Quentric, M., Himmerkus, N., Koike, T., Poulter, J., Klootwijk, E., Robinette, S. L., Howie, A. J. et al. (2012) Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations. Nephron Physiol. 122, 1-6 CrossRef PubMed
41. Wang, S.-K., Aref, P., Hu, Y., Milkovich, R. N., Simmer, J. P., El-Khateeb, M., Daggag, H., Baqain, Z. H. and Hu, J. C.-C. (2013) FAM20A mutations can cause enamel-renal syndrome (ERS). PLoS Genet. 9, e1003302 CrossRef PubMed
42. Kawasaki, K. (2011) The SCPP gene family and the complexity of hard tissues in vertebrates. Cells Tissues Organs 194, 108-112 CrossRef PubMed
43. Blomb̈ack, B., Blomb̈ack, M., Edman, P. and Hessel, B. (1962) Amino acid sequence and the occurrence of phosphorus in human fibrinopeptides. Nature 193, 883-884 CrossRef
44. Procino, G., Carmosino, M., Marin, O., Brunati, A. M., Contri, A., Pinna, L. A., Mannucci, R., Nielsen, S., Kwon, T.-H., Svelto, M. et al. (2003) Ser-256 phosphorylation dynamics of Aquaporin 2 during maturation from the ER to the vesicular compartment in renal cells. FASEB J. 17, 1886-1888 PubMed
45. Tibaldi, E., Arrigoni, G., Martinez, H. M., Inagaki, K., Shimasaki, S. and Pinna, L. A. (2010) Golgi apparatus casein kinase phosphorylates bioactive Ser-6 of bone morphogenetic protein 15 and growth and differentiation factor 9. FEBS Lett. 584, 801-805 CrossRef PubMed
46. Castagnola, M., Messana, I., Inzitari, R., Fanali, C., Cabras, T., Morelli, A., Pecoraro, A. M., Neri, G., Torrioli, M. G. and Gurrieri, F. (2008) Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J. Proteome Res. 7, 5327-5332 CrossRef PubMed
47. Saxena, A., Padmanabha, R. and Glover, C. V. (1987) Isolation and sequencing of cDNA clones encoding alpha and beta subunits of Drosophila melanogaster casein kinase II. Mol. Cell. Biol. 7, 3409-3417 PubMed
48. Chantalat, L., Leroy, D., Filhol, O., Nueda, A., Benitez, M. J., Chambaz, E. M., Cochet, C. and Dideberg, O. (1999) Crystal structure of the human protein kinase CK2 regulatory subunit reveals its zinc finger-mediated dimerization. EMBO J. 18, 2930-2940 CrossRef PubMed
49. Niefind, K., Guerra, B., Ermakowa, I. and Issinger, O. G. (2001) Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. EMBO J. 20, 5320-5331 CrossRef PubMed
50. Hathaway, G. M. and Traugh, J. A. (1982) Casein kinases: multipotential protein kinases. Curr. Top. Cell. Regul. 21, 101-127 PubMed
51. Pinna, L. A. (1990) Casein kinase 2: an "eminence grise" in cellular regulation? Biochim. Biophys. Acta 1054, 267-284 CrossRef PubMed
52. Issinger, O. G. (1993) Casein kinases: pleiotropic mediators of cellular regulation. Pharmacol. Ther. 59, 1-30 CrossRef PubMed
53. Allende, J. E. and Allende, C. C. (1995) Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. FASEB J. 9, 313-323 PubMed
54. Glover, 3rd, C. V. (1998) On the physiological role of casein kinase II in Saccharomyces cerevisiae. Prog. Nucleic Acid Res. Mol. Biol. 59, 95-133 CrossRef PubMed
55. Pinna, L. A. (2002) Protein kinase CK2: a challenge to canons. J. Cell Sci. 115, 3873-3878 CrossRef PubMed
56. Litchfield, D. W. (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369, 1-15 CrossRef PubMed
57. Litchfield, D. W. and Lüscher, B. (1993) Casein kinase II in signal transduction and cell cycle regulation. Mol. Cell. Biochem. 127-128, 187-199 CrossRef
58. Pyerin, W. and Ackermann, K. (2003) The genes encoding human protein kinase CK2 and their functional links. Prog. Nucleic Acid Res. Mol. Biol. 74, 239-273 CrossRef PubMed
59. Pinna, L. A. (2003) The raison d'être of constitutively active protein kinases: the lesson of CK2. Acc. Chem. Res. 36, 378-384 CrossRef PubMed
60. Meggio, F. and Pinna, L. A. (2003) One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17, 349-368 CrossRef PubMed
61. Ahmed, K., Gerber, D. A. and Cochet, C. (2002) Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol. 12, 226-230 CrossRef PubMed
62. Tawfic, S., Yu, S., Wang, H., Faust, R., Davis, A. and Ahmed, K. (2001) Protein kinase CK2 signal in neoplasia. Histol. Histopathol. 16, 573-582 PubMed
63. Trembley, J. H., Chen, Z., Unger, G., Slaton, J., Kren, B. T., Van Waes, C. and Ahmed, K. (2010) Emergence of protein kinase CK2 as a key target in cancer therapy. Biofactors 36, 187-195 CrossRef PubMed
64. Ruzzene, M. and Pinna, L. A. (2010) Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim. Biophys. Acta 1804, 499-504 CrossRef PubMed
65. Blanquet, P. R. (2000) Casein kinase 2 as a potentially important enzyme in the nervous system. Prog. Neurobiol. 60, 211-246 CrossRef PubMed
66. Guerra, B. and Issinger, O.-G. (2008) Protein kinase CK2 in human diseases. Curr. Med. Chem. 15, 1870-1886 CrossRef PubMed
67. Singh, N. N. and Ramji, D. P. (2008) Protein kinase CK2, an important regulator of the inflammatory response? J. Mol. Med. 86, 887-897 CrossRef PubMed
68. Sarno, S., Papinutto, E., Franchin, C., Bain, J., Elliott, M., Meggio, F., Kazimierczuk, Z., Orzeszko, A., Zanotti, G., Battistutta, R. et al. (2011) ATP site-directed inhibitors of protein kinase CK2: an update. Curr. Top. Med. Chem. 11, 1340-1351 CrossRef PubMed
69. Cozza, G., Pinna, L. A. and Moro, S. (2012) Protein kinase CK2 inhibitors: a patent review. Expert Opin. Ther. Pat. 22, 1081-1097 CrossRef PubMed
70. Cozza, G., Pinna, L. A. and Moro, S. (2013) Kinase CK2 inhibition: an update. Curr. Med. Chem. 20, 671-693 CrossRef PubMed
71. Pinna, L. A. (2013) Protein Kinase CK2, Wiley-Blackwell, Hoboken CrossRef
72. Hathaway, G. M. and Traugh, J. A. (1979) Cyclic nucleotide-independent protein kinases from rabbit reticulocytes. Purification of casein kinases. J. Biol. Chem. 254, 762-768 PubMed
73. Ackermann, K., Neidhart, T., Gerber, J., Waxmann, A. and Pyerin, W. (2005) The catalytic subunit alpha' gene of human protein kinase CK2 (CSNK2A2): genomic organization, promoter identification and determination of Ets1 as a key regulator. Mol. Cell. Biochem. 274, 91-101 CrossRef PubMed
74. Xu, X., Toselli, P. A., Russell, L. D. and Seldin, D. C. (1999) Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. Nat. Genet. 23, 118-121 CrossRef PubMed
75. Filhol, O., Martiel, J.-L. and Cochet, C. (2004) Protein kinase CK2: a new view of an old molecular complex. EMBORep. 5, 351-355 CrossRef PubMed
76. Lolli, G., Pinna, L. A. and Battistutta, R. (2012) Structural determinants of protein kinase CK2 regulation by autoinhibitory polymerization. ACS Chem. Biol. 7, 1158-1163 CrossRef PubMed
77. Lolli, G., Ranchio, A. and Battistutta, R. (2014) Active form of the protein kinase CK2 a2fs2 holoenzyme is a strong complex with symmetric architecture. ACS Chem. Biol. 9, 366-371 CrossRef PubMed
78. Deshiere, A., Duchemin-Pelletier, E., Spreux, E., Ciais, D., Combes, F., Vandenbrouck, Y, Coute, Y, Mikaelian, I., Giusiano, S., Charpin, C. et al. (2013) Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction. Oncogene 32, 1373-1383 CrossRef PubMed
79. Di Maira, G., Brustolon, F., Bertacchini, J., Tosoni, K., Marmiroli, S., Pinna, L. A. and Ruzzene, M. (2007) Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level. Oncogene 26, 6915-6926 CrossRef PubMed
80. Guerra, B. and Issinger, O. G. (1999) Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20, 391-408 CrossRef PubMed
81. Pierre, F., Chua, P. C, O'Brien, S. E, Siddiqui-Jain, A., Bourbon, P., Haddach, M., Michaux, J., Nagasawa, J., Schwaebe, M. K., Stefan, E. et al. (2011)DiscoveryandSAR of 5-(3-chlorophenylamino)benzo[c][2, 6]naphthyridine-8- carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. J. Med. Chem. 54, 635-654 CrossRef PubMed
82. Dominguez, I., Degano, I. R., Chea, K., Cha, J., Toselli, P. andSeldin, D. C. (2011) CK2a is essential for embryonic morphogenesis. Mol. Cell. Biochem. 356, 209-216 CrossRef PubMed
83. Manni, S., Brancalion, A., Tubi, L. Q., Colpo, A., Pavan, L, Cabrelle, A., Ave, E., Zaffino, F., Di Maira, G., Ruzzene, M. et al. (2012) Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response. Clin. Cancer Res. 18, 1888-1900 CrossRef PubMed
84. Hosoi, T., Korematsu, K., Horie, N., Suezawa, T., Okuma, Y, Nomura, Y. and Ozawa, K. (2012) Inhibition of casein kinase 2 modulates XBP1-GRP78 arm of unfolded protein responses in cultured glial cells. PLoS ONE 7, e40144 CrossRef PubMed
85. Buontempo, F., Orsini, E., Martins, L. R., Antunes, I., Lonetti, A., Chiarini, F., Tabellini, G., Evangelisti, C, Evangelisti, C, Melchionda, F. et al. (2014) Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling. Leukemia 28, 543-553 CrossRef PubMed
86. Duncan, J. S., Turowec, J. P., Duncan, K. E., Vilk, G., Wu, C, Luscher, B., Li, S. S.-C, Gloor, G. B. and Litchfield, D. W. (2011) A peptide-based target screen implicates the protein kinase CK2 in the global regulation of caspase signaling. Sci. Signal. 4, ra30 CrossRef PubMed
87. Wu, H., Symes, K., Seldin, D. C. and Dominguez, I. (2009) Threonine 393 of/3-catenin regulates interaction with Axin. J. Cell. Biochem. 108, 52-63 CrossRef PubMed
88. Torres, J. and Pulido, R. (2001) The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C-terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276, 993-998 CrossRef PubMed
89. McElhinny J. A., Trushin, S. A., Bren, G. D., Chester, N. and Paya, C. V. (1996) Casein kinase II phosphorylates kBa at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16, 899-906 PubMed
90. Tsuchiya, Y, Taniguchi, H., Ito, Y, Morita, T, Karim, M. R., Ohtake, N., Fukagai, K., Ito, T, Okamuro, S., Iemura, S.-I. et al. (2013) The casein kinase 2-nrf1 axis controls the clearance of ubiquitinated proteins by regulating proteasome gene expression. Mol. Cell. Biol. 33, 3461-3472 CrossRef PubMed
91. Nguyen, L X. T. and Mitchell, B. S. (2013) Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA. Proc. Natl. Acad. Sci. U.S.A. 110, 20681-20686 CrossRef PubMed
92. Di Maira, G., Salvi, M., Arrigoni, G., Marin, O., Sarno, S., Brustolon, F., Pinna, L. A. and Ruzzene, M. (2005) Protein kinase CK2 phosphorylates and upregulates Akt/PKB. Cell Death Differ. 12, 668-677 CrossRef PubMed
93. Di Maira, G., Brustolon, F., Pinna, L A. and Ruzzene, M. (2009) Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells. Cell. Mol. Life Sci. 66, 3363-3373 CrossRef PubMed
94. Bian, Y, Ye, M., Wang, C, Cheng, K., Song, C, Dong, M., Pan, Y, Qin, H. and Zou, H. (2013) Global screening of CK2 kinase substrates by an integrated phosphoproteomics workflow. Sci. Rep. 3, 3460 CrossRef PubMed
95. Ruzzene, M., Penzo, D. and Pinna, L. A. (2002) Protein kinase CK2 inhibitor 4, 5, 6, 7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. Biochem. J. 364, 41-47 PubMed
96. Gyenis, L, Kuś, A., Bretner, M. and Litchfield, D. W. (2013) Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2. J. Proteomics 81, 70-79 CrossRef PubMed
97. Gyenis, L, Turowec, J. P., Bretner, M. and Litchfield, D. W. (2013) Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2. Biochim. Biophys. Acta 1834, 1352-1358 CrossRef PubMed
98. Ljubimov, A. V., Caballero, S., Aoki, A. M., Pinna, L. A., Grant, M. B. and Castellon, R. (2004) Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 45, 4583-4591 CrossRef PubMed
99. Li, X., Shi, X., Liang, D.-Y and Clark, J. D. (2005) Spinal CK2 regulates nociceptive signaling in models of inflammatory pain. Pain 115, 182-190 CrossRef PubMed
100. Kim, G. S., Jung, J. E., Niizuma, K. and Chan, P. H. (2009) CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia. J. Neurosci. 29, 14779-14789 CrossRef PubMed
101. Sass, G., Klinger, N., Sirma, H., Hashemolhosseini, S., Hellerbrand, C, Neureiter, D., Wege, H., Ocker, M. and Tiegs, G. (2011) Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT. Int. J. Oncol. 39, 433-442 PubMed
102. Prudent, R., Moucadel, V, Nguyen, C.-H., Barette, C, Schmidt, F., Florent, J.-C, Lafanechere, L, Sautel, C. F., Duchemin-Pelletier, E., Spreux, E. et al. (2010) Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2. Cancer Res. 70, 9865-9874 CrossRef PubMed
103. Hung, M.-S., Xu, Z, Chen, Y, Smith, E., Mao, J.-H., Hsieh, D., Lin, Y.-C, Yang, C.-T., Jablons, D. M. and You, L. (2013) Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model. Int. J. Oncol. 43, 1517-1522 PubMed
104. Siddiqui-Jain, A., Drygin, D., Streiner, N., Chua, P., Pierre, F., O'Brien, S. E., Bliesath, J., Omori, M., Huser, N., Ho, C. et al. (2010) CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer Res. 70, 10288-10298 CrossRef PubMed
105. Bliesath, J., Huser, N., Omori, M., Bunag, D., Proffitt, C, Streiner, N., Ho, C, Siddiqui-Jain, A., O'Brien, S. E., Lim, J. K. C. et al. (2012) Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells. Cancer Lett. 322, 113-118 CrossRef PubMed
106. Martins, L R., Lucio, P., Melao, A., Antunes, I., Cardoso, B. A., Stansfield, R., Bertilaccio, M. T. S., Ghia, P., Drygin, D., Silva, M. G. et al. (2014) Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic. Leukemia 28, 179-182 CrossRef PubMed
107. Zheng, Y, McFarland, B. C, Drygin, D., Yu, H., Bellis, S. L, Kim, H., Bredel, M. and Benveniste, E. N. (2013) Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma. Clin. Cancer Res. 19, 6484-6494 CrossRef PubMed
108. Son, Y H., Song, J. S., Kim, S. H. and Kim, J. (2013) Pharmacokinetic characterization of CK2 inhibitor CX-4945. Arch. Pharm. Res. 36, 840-845 CrossRef PubMed
109. Perea, S. E, Reyes, O., Puchades, Y, Mendoza, O., Vispo, N. S., Torrens, I., Santos, A., Silva, R., Acevedo, B., Lopez, E. et al. (2004) Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2). Cancer Res. 64, 7127-7129 CrossRef PubMed
110. Perera, Y, Farina, H. G., Hernandez, I., Mendoza, O., Serrano, J. M., Reyes, O., Gomez, D. E, Gomez, R. E., Acevedo, B. E, Alonso, D. F. et al. (2008) Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice. Int. J. Cancer 122, 57-62 CrossRef PubMed
111. Perea, S. E, Reyes, O., Baladron, I., Perera, Y, Farina, H., Gil, J., Rodriguez, A., Bacardi, D., Marcelo, J. L, Cosme, K. et al. (2008) CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo. Mol. Cell. Biochem. 316, 163-167 CrossRef PubMed
112. Solares, A. M., Santana, A., Baladron, I., Valenzuela, C, Gonzalez, C. A., D́iaz, A., Castillo, D., Ramos, T., Gomez, R., Alonso, D. F. et al. (2009) Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies. BMC Cancer 9, 146 CrossRef PubMed
113. Farina, H. G., Benavent Acero, F., Perera, Y, Rodŕiguez, A., Perea, S. E., Castro, B. A., Gomez, R., Alonso, D. F. and Gomez, D. E. (2011) CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo. Exp. Cell Res. 317, 1677-1688 CrossRef PubMed
114. Perea, S. E, Filhol, O. and Cochet, C. (2013) CGIB-300 anticancer peptide impairs casein kinase 2 (CK2)-dependent phosphorylation in vitro. 7th International Conference on Protein Kinase CK2, Lublin, Poland, 10-13 September 2013
115. Cochet, C. (2013) Targeting the CK2 subunits: challenge and usefulness. 7th International Conference on Protein Kinase CK2, Lublin, Poland, 10-13 September 2013
116. Zanin, S., Sandre, M., Marin, O., Cozza, G., Girardi, C, Pinna, L. A. and Ruzzene, M. (2013) Variable effects of different CK2 inhibition strategies in tumor cells. 7th International Conference on Protein Kinase CK2, Lublin, Poland, 10-13 September 2013
117. Salvi, M., Sarno, S., Marin, O., Meggio, F., Itarte, E. and Pinna, L. A. (2006) Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits. FEBS Lett. 580, 3948-3952 CrossRef PubMed
118. Perera, Y, Farina, H. G., Gil, J., Rodriguez, A., Benavent, F., Castellanos, L, Gomez R. E., Acevedo, B. E, Alonso, D. F. and Perea, S. E. (2009) Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity. Mol. Cancer Ther. 8, 1189-1196 CrossRef PubMed
119. Perera, Y, Costales, H. C, Diaz, Y, Reyes, O., Farina, H. G., Mendez, L, Gomez, R. E., Acevedo, B. E, Gomez, D. E., Alonso, D. F. et al. (2012) Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization. J. Pept. Sci. 18, 215-223 CrossRef PubMed
120. Zanin, S., Sandre, M., Marin, O., Cozza, G., Pinna, L. A. and Ruzzene, M. (2013) A new strategy to target protein kinase CK2 in tumor cells. 2013 Annual Meeting of the American Society for Cell Biology, New Orleans, LA, U.S.A., 14-18 December 2013
121. Di Maira, G., Brustolon, F., Tosoni, K., Belli, S., Kramer, S. D., Pinna, L. A. and Ruzzene, M. (2008) Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis. Mol. Cell. Biochem. 316, 155-161 CrossRef PubMed
122. Zanin, S., Borgo, C, Girardi, C, O'Brien, S. E, Miyata, Y, Pinna, L A., Donella-Deana, A. and Ruzzene, M. (2012) Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells. PLoS ONE 7, e49193 CrossRef PubMed
123. Glavy, J. S., Horwitz, S. B. and Orr, G. A. (1997) Identification of the in vivo phosphorylation sites for acidic-directed kinases in murine mdr1b P-glycoprotein. J. Biol. Chem. 272, 5909-5914 CrossRef PubMed
124. 249. Mol. Pharmacol. 82, 488-499 CrossRef PubMed
125. Piazza, F. A., Ruzzene, M., Gurrieri, C, Montini, B., Bonanni, L, Chioetto, G., Di Maira, G., Barbon, F., Cabrelle, A., Zambello, R. et al. (2006) Multiple myeloma cell survival relies on high activity of protein kinase CK2. Blood 108, 1698-1707 CrossRef PubMed
126. Silva, A., Jotta, P. Y, Silveira, A. B., Ribeiro, D., Brandalise, S. R., Yunes, J. A. and Barata, J. T. (2010) Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2-and y-secretase inhibitors. Haematologica 95, 674-678 CrossRef PubMed
127. Borgo, C, Cesaro, L, Salizzato, V, Ruzzene, M., Massimino, M. L, Pinna, L. A. and Donella-Deana, A. (2013) Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives. Mol. Oncol. 7, 1103-1115 CrossRef PubMed
128. Koronkiewicz, M., Chilmonczyk, Z. and Kazimierczuk, Z. (2013) Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro. Anticancer Res. 33, 4891-4899 PubMed
129. Prins, R. C, Burke, R. T., Tyner, J. W., Druker, B. J., Loriaux, M. M. and Spurgeon, S. E. (2013) CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway. Leukemia 27, 2094-2096 CrossRef PubMed
130. Manni, S., Brancalion, A., Mandato, E., Tubi, L. Q., Colpo, A., Pizzi, M., Cappellesso, R., Zaffino, F., Di Maggio, S. A., Cabrelle, A. et al. (2013) Protein kinase CK2 inhibition down modulates the NF-KB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells. PLoS ONE 8, e75280 CrossRef PubMed
131. Smith, M. C, Bayless, A. M., Goddard, E. T. and Davido, D. J. (2011) CK2 inhibitors increase the sensitivity of HSV-1 to interferon-. Antiviral Res. 91, 259-266 CrossRef PubMed
132. Trembley, J. H., Unger, G. M., Tobolt, D. K., Korman, V L, Wang, G., Ahmad, K. A., Slaton, J. W., Kren, B. T. and Ahmed, K. (2011) Systemic administration of antisense oligonucleotides simultaneously targeting CK2a and a subunits reduces orthotopic xenograft prostate tumors in mice. Mol. Cell. Biochem. 356, 21-35 CrossRef PubMed
133. Brown, M. S., Diallo, O. T., Hu, M., Ehsanian, R., Yang, X., Arun, P., Lu, H., Korman, V., Unger, G., Ahmed, K. et al. (2010) CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitroor in vivovia sub-50-nm nanocapsules. Clin. Cancer Res. 16, 2295-2307 CrossRef PubMed
134. Trembley, J. H., Unger, G. M., Korman, V. L., Tobolt, D. K., Kazimierczuk, Z., Pinna, L. A., Kren, B. T. and Ahmed, K. (2012) Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells. Cancer Lett. 315, 48-58 CrossRef PubMed
135. Rowles, J., Slaughter, C., Moomaw, C., Hsu, J. and Cobb, M. H. (1991) Purification of casein kinase I and isolation of cDNAs encoding multiple casein kinase I-like enzymes. Proc. Natl. Acad. Sci. U.S.A. 88, 9548-9552 CrossRef PubMed
136. Hanks, S. K. and Hunter, T. (1995) Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9, 576-596 PubMed
137. Rivers, A., Gietzen, K. F., Vielhaber, E. and Virshup, D. M. (1998) Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle. J. Biol. Chem. 273, 15980-15984 CrossRef PubMed
138. Budini, M., Jacob, G., Jedlicki, A., Pérez, C., Allende, C. C. and Allende, J. E. (2009) Autophosphorylation of carboxy-terminal residues inhibits the activity of protein kinase CK1α. J. Cell. Biochem. 106, 399-408 CrossRef PubMed
139. Xu, R. M., Carmel, G., Sweet, R. M., Kuret, J. and Cheng, X. (1995) Crystal structure of casein kinase-1, a phosphate-directed protein kinase. EMBO J. 14, 1015-1023 PubMed
140. Longenecker, K. L., Roach, P. J. and Hurley, T. D. (1996) Three-dimensional structure of mammalian casein kinase I: molecular basis for phosphate recognition. J. Mol. Biol. 257, 618-631 CrossRef PubMed
141. Davidson, G., Wu, W., Shen, J., Bilic, J., Fenger, U., Stannek, P., Glinka, A. and Niehrs, C. (2005) Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438, 867-872 CrossRef PubMed
142. Songyang, Z., Lu, K. P., Kwon, Y. T., Tsai, L. H., Filhol, O., Cochet, C., Brickey, D. A., Soderling, T. R., Bartleson, C., Graves, D. J. et al. (1996)
143. Marin, O., Burzio, V., Boschetti, M., Meggio, F., Allende, C. C., Allende, J. E. and Pinna, L. A. (2002) Structural features underlying the multisite phosphorylation of the A domain of the NF-AT4 transcription factor by protein kinase CK1. Biochemistry 41, 618-627 CrossRef PubMed
144. Marin, O., Bustos, V. H., Cesaro, L., Meggio, F., Pagano, M. A., Antonelli, M., Allende, C. C., Pinna, L. A. and Allende, J. E. (2003) A noncanonical sequence phosphorylated by casein kinase 1 in β-catenin may play a role in casein kinase 1 targeting of important signaling proteins. Proc. Natl. Acad. Sci. U.S.A. 100, 10193-10200 CrossRef PubMed
145. Bustos, V. H., Ferrarese, A., Venerando, A., Marin, O., Allende, J. E. and Pinna, L. A. (2006) The first armadillo repeat is involved in the recognition and regulation of β-catenin phosphorylation by protein kinase CK1. Proc. Natl. Acad. Sci. U.S.A. 103, 19725-19730 CrossRef PubMed
146. Ferrarese, A., Marin, O., Bustos, V. H., Venerando, A., Antonelli, M., Allende, J. E. and Pinna, L. A. (2007) Chemical dissection of the APC repeat 3 multistep phosphorylation by the concerted action of protein kinases CK1 and GSK3. Biochemistry 46, 11902-11910 CrossRef PubMed
147. Venerando, A., Marin, O., Cozza, G., Bustos, V. H., Sarno, S. and Pinna, L. A. (2010) Isoform specific phosphorylation of p53 by protein kinase CK1. Cell. Mol. Life Sci. 67, 1105-1118 CrossRef PubMed
148. O'Shea, J. P., Chou, M. F., Quader, S. A., Ryan, J. K., Church, G. M. and Schwartz, D. (2013) pLogo: a probabilistic approach to visualizing sequence motifs. Nat. Methods 10, 1211-1212 CrossRef PubMed
149. Knippschild, U., Gocht, A., Wolff, S., Huber, N., Löhler, J. and Stöter, M. (2005) The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell. Signal. 17, 675-689 CrossRef PubMed
150. Cheong, J. K. and Virshup, D. M. (2011) Casein kinase 1: complexity in the family. Int. J. Biochem. Cell Biol. 43, 465-469 CrossRef PubMed
151. Perez, D. I., Gil, C. and Martinez, A. (2011) Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. Med. Res. Rev. 31, 924-954 CrossRef PubMed
152. Knippschild, U., Wolff, S., Giamas, G., Brockschmidt, C., Wittau, M., Würl, P. U., Eismann, T. and Stöter, M. (2005) The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development. Onkologie 28, 508-514 CrossRef PubMed
153. Cobb, M. H. and Rosen, O. M. (1983) Description of a protein kinase derived from insulin-treated 3T3-L1 cells that catalyzes the phosphorylation of ribosomal protein S6 and casein. J. Biol. Chem. 258, 12472-12481 PubMed
154. Knippschild, U., Milne, D. M., Campbell, L. E., DeMaggio, A. J., Christenson, E., Hoekstra, M. F. and Meek, D. W. (1997) p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase- directed drugs. Oncogene 15, 1727-1736 CrossRef PubMed
155. Hirner, H., Gunes, C, Bischof, J., Wolff, S., Grothey, A., Kuhl, M., Oswald, F., Wegwitz, F., Bösl, M. R., Trauzold, A. et al. (2012) Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo. PLoS ONE 7, e29709 CrossRef PubMed
156. Gross, S. D., Hoffman, D. P., Fisette, P. L, Baas, P. and Anderson, R. A. (1995) A phosphatidylinositol 4, 5-bisphosphate-sensitive casein kinase I alpha associates with synaptic vesicles and phosphorylates a subset of vesicle proteins. J. Cell Biol. 130, 711-724 CrossRef PubMed
157. Chijiwa, T., Hagiwara, M. and Hidaka, H. (1989) A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloroisoquinoline-8- sulfonamide, and affinity purification of casein kinase I from bovine testis. J. Biol. Chem. 264, 4924-4927 PubMed
158. Mashhoon, N., DeMaggio, A. J., Tereshko, V., Bergmeier, S. C, Egli, M., Hoekstra, M. F. and Kuret, J. (2000) Crystal structure of a conformation- selective casein kinase-1 inhibitor. J. Biol. Chem. 275, 20052-20060 CrossRef PubMed
159. Walton, K. M., Fisher, K., Rubitski, D., Marconi, M., Meng, Q.-J., Sladek, M., Adams, J., Bass, M., Chandrasekaran, R., Butler, T. et al. (2009) Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period. J. Pharmacol. Exp. Ther. 330, 430-439 CrossRef PubMed
160. Rena, G., Bain, J., Elliott, M. and Cohen, P. (2004) D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep. 5, 60-65 CrossRef PubMed
161. Peifer, C, Abadleh, M., Bischof, J., Hauser, D., Schattel, V, Hirner, H., Knippschild, U. and Laufer, S. (2009) 3, 4-Diaryl-isoxazoles and-imidazoles as potent dual inhibitors of p38a mitogen activated protein kinase and casein kinase 18. J. Med. Chem. 52, 7618-7630 CrossRef PubMed
162. Cozza, G., Gianoncelli, A., Montopoli, M., Caparrotta, L, Venerando, A., Meggio, F, Pinna, L. A., Zagotto, G. and Moro, S. (2008) Identification of novel protein kinase CK1 delta (CK1S) inhibitors through structure-based virtual screening. Bioorg. Med. Chem. Lett. 18, 5672-5675 CrossRef PubMed
163. Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C, Hang, B. I., Waterson, A. G. et al. (2010) Small-molecule inhibition of Wnt signaling through activation of casein kinase 1a. Nat. Chem. Biol. 6, 829-836 CrossRef PubMed
164. Zelenak, C, Eberhard, M., Jilani, K., Qadri, S. M., Macek, B. and Lang, F. (2012) Protein kinase CK1a regulates erythrocyte survival. Cell. Physiol. Biochem. 29, 171-180 CrossRef PubMed
165. Yim, D. G. R. and Virshup, D. M. (2013) Unwinding the Wnt action of casein kinase1. Cell Res. 23, 737-738 CrossRef PubMed
166. Venerando, A., Girardi, C, Ruzzene, M. and Pinna, L. A. (2013) Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activation. Biochem. J. 452, 131-137 PubMed
167. Wang, P. C, Vancura, A., Desai, A., Carmel, G. and Kuret, J. (1994) Cytoplasmic forms of fission yeast casein kinase-1 associate primarily with the particulate fraction of the cell. J. Biol. Chem. 269, 12014-12023 PubMed
168. Vancura, A., Sessler, A., Leichus, B. and Kuret, J. (1994) A prenylation motif is required for plasma membrane localization and biochemical function of casein kinase I in budding yeast. J. Biol. Chem. 269, 19271-19278 PubMed
169. Sillibourne, J. E., Milne, D. M., Takahashi, M., Ono, Y and Meek, D. W. (2002) Centrosomal anchoring of the protein kinase CK15 mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450. J. Mol. Biol. 322, 785-797 CrossRef PubMed
170. Kim, W., Kim, M. and Jho, E. (2013) Wnt/-catenin signalling: from plasma membrane to nucleus. Biochem. J. 450, 9-21 CrossRef PubMed
171. Cruciat, C.-M., Dolde, C, de Groot, R. E. A., Ohkawara, B., Reinhard, C, Korswagen H. C. and Niehrs C. (2013) RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-catenin signaling. Science 339, 1436-1441 CrossRef PubMed
172. 2+-independent phosphorylation of tubulin and microtubule-associated protein-2 by glycogen synthase (casein) kinase-1. Biochem. Biophys. Res. Commun. 121, 19-26 CrossRef PubMed
173. Shanware, N. P., Hutchinson, J. A., Kim, S. H., Zhan, L, Bowler, M. J. and Tibbetts, R. S. (2011) Casein kinase 1-dependent phosphorylation of familial advanced sleep phase syndrome-associated residues controls PERIOD 2 stability. J. Biol. Chem. 286, 12766-12774 CrossRef PubMed
174. Bhattacharya, D., Ansari, I. H. and Striker, R. (2009) The flaviviral methyltransferase is a substrate of casein kinase1. Virus Res. 141, 101-104 CrossRef PubMed
175. Quintavalle, M., Sambucini, S., Summa, V, Orsatti, L, Talamo, F., De Francesco, R. and Neddermann, P. (2007) Hepatitis C virus NS5A is a direct substrate of casein kinase I-a, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors. J. Biol. Chem. 282, 5536-5544 CrossRef PubMed
176. Allocco, J. J., Donald, R., Zhong, T., Lee, A., Tang, Y. S., Hendrickson, R. C, Liberator, P. and Nare, B. (2006) Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro. Int. J. Parasitol. 36, 1249-1259 CrossRef PubMed
177. Rachidi, N., Taly J. F, Durieu, E., Leclercq, O., Aulner, N., Prina, E, Pescher, P., Notredame, C, Meijer, L. and Spath, G. F. (2014) Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection. Antimicrob. Agents Chemother. 58, 1501-1515 CrossRef
178. Meng, Q.-J., Logunova, L, Maywood, E. S., Gallego, M., Lebiecki, J., Brown, T. M., Sladek, M., Semikhodskii, A. S., Glossop, N. R. J., Piggins, H. D. et al. (2008) Setting clock speed in mammals: the CK1e tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron 58, 78-88 CrossRef PubMed
179. Yasojima, K., Kuret, J., DeMaggio, A. J., McGeer, E. and McGeer, P. L. (2000) Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain. Brain Res. 865, 116-120 CrossRef PubMed
180. Chauhan, A., Chauhan, V. P., Murakami, N., Brockerhoff, H. and Wisniewski, H. M. (1993) Amyloid/3-protein stimulates casein kinase I and casein kinase II activities. Brain Res. 629, 47-52 CrossRef PubMed
181. Hanger, D. P., Byers, H. L, Wray S., Leung, K.-Y, Saxton, M. J., Seereeram, A., Reynolds, C. H., Ward, M. A. and Anderton, B. H. (2007) Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 282, 23645-23654 CrossRef PubMed
182. Waxman, E. A. and Giasson, B. I. (2008) Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J. Neuropathol. Exp. Neurol. 67, 402-416 CrossRef PubMed
183. Masuda, K., Ono, M., Okamoto, M., Morikawa, W., Otsubo, M., Migita, T., Tsuneyoshi, M., Okuda, H., Shuin, T., Naito, S. et al. (2003) Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells. Int. J. Cancer 105, 803-810 CrossRef PubMed
184. Brockschmidt, C., Hirner, H., Huber, N., Eismann, T., Hillenbrand, A., Giamas, G., Radunsky, B., Ammerpohl, O., Bohm, B., Henne-Bruns, D. et al. (2008) Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitroand in vivo. Gut 57, 799-806 CrossRef PubMed
185. Dumaz, N., Milne, D. M. and Meek, D. W. (1999) Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15. FEBS Lett. 463, 312-316 CrossRef PubMed
186. MacLaine, N. J., Oster, B., Bundgaard, B., Fraser, J. A., Buckner, C., Lazo, P. A., Meek, D. W., Höllsberg, P. and Hupp, T. R. (2008) A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection. J. Biol. Chem. 283, 28563-28573 CrossRef PubMed
187. Garzia, L., D'Angelo, A., Amoresano, A., Knauer, S. K., Cirulli, C., Campanella, C., Stauber, R. H., Steegborn, C., Iolascon, A. and Zollo, M. (2008) Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility. Oncogene 27, 1853-1864 CrossRef PubMed
188. Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V. et al. (2009) A mutant-p53/Smad complex opposes p63 to empower TGFβ-induced metastasis. Cell 137, 87-98 CrossRef PubMed
189. Ubersax, J. A. and Ferrell, Jr, J. E. (2007) Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 8, 530-541 CrossRef PubMed
190. Ruzzene, M., Tosoni, K., Zanin, S., Cesaro, L. and Pinna, L. A. (2011) Protein kinase CK2 accumulation in "oncophilic" cells: causes and effects. Mol. Cell. Biochem. 356, 5-10 CrossRef PubMed